Showing posts with label study. Show all posts
Showing posts with label study. Show all posts

Thursday, February 14, 2013

#LDN as treatment- 4 #Fibromyalgia - Positive Results in Trial

Published in February 2013, study to determine the effectiveness of naltrexone in low doses for fibromyalgia has again displayed positive results as a good treatment option for this condition.  Low Dose Naltrexone showed significant reduction in baseline pain, improvement with general quality of life and also mood improvement.  

Abstract of study is below.


Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels.



 2013 Feb;65(2):529-38. doi: 10.1002/art.37734.

Younger J, Noor N, McCue R, Mackey S.

Source

Stanford University School of Medicine, Palo Alto, California. jarred.younger@stanford.edu.

Abstract

OBJECTIVE:

To determine whether low dosages (4.5 mg/day) of naltrexone reduce fibromyalgia severity as compared with the nonspecific effects of placebo. In this replication and extension study of a previous clinical trial, we tested the impact of low-dose naltrexone on daily self-reported pain. Secondary outcomes included general satisfaction with life, positive mood, sleep quality, and fatigue.

METHODS:

Thirty-one women with fibromyalgia participated in the randomized, double-blind, placebo-controlled, counterbalanced, crossover study. During the active drug phase, participants received 4.5 mg of oral naltrexone daily. An intensive longitudinal design was used to measure daily levels of pain.

RESULTS:

When contrasting the condition end points, we observed a significantly greater reduction of baseline pain in those taking low-dose naltrexone than in those taking placebo (28.8% reduction versus 18.0% reduction; P = 0.016). Low-dose naltrexone was also associated with improved general satisfaction with life (P = 0.045) and with improved mood (P = 0.039), but not improved fatigue or sleep. Thirty-two percent of participants met the criteria for response (defined as a significant reduction in pain plus a significant reduction in either fatigue or sleep problems) during low-dose naltrexone therapy, as contrasted with an 11% response rate during placebo therapy (P = 0.05). Low-dose naltrexone was rated equally tolerable as placebo, and no serious side effects were reported.

CONCLUSION:

The preliminary evidence continues to show that low-dose naltrexone has a specific and clinically beneficial impact on fibromyalgia pain. The medication is widely available, inexpensive, safe, and well-tolerated. Parallel-group randomized controlled trials are needed to fully determine the efficacy of the medication.
Copyright © 2013 by the American College of Rheumatology.
PMID:
 
23359310
 
[PubMed - in process]

The following toggler user interface control may not be accessible. Tab to the next button to revert the control to an accessible version.
Destroy user interface control




Low-dose naltrexone for the treatment of fib... [Arthritis Rheum. 2013] - PubMed - NCBI:

'via Blog this'

Sunday, December 9, 2012

Study on Monkeys w/ - Probiotic Worm Treatment ~ Sounds Good!


Another study, very small study, testing parasite worm (Helminth) eggs that shows that the treatment is effective with improving the gut bacteria balance in monkeys. Awesome.   I have been reading more and more about this treatment.  I may actually inquire about this the next time i see my GI doctor.

ARTICLE HIGHLIGHTS
  •  In animal models of autoimmunity these worms have suppressed inflammation, and clinical trials indicate that helminth therapy can be beneficial in inflammatory bowel diseases.

Probiotic Worm treatment may improve symptoms of colitis by restoring gut bacteria to healthy state 

November 15, 2012 in Diseases, Conditions, Syndromes 

A new study on monkeys with chronic diarrhea that were treated by microscopic parasite worm (helminth) eggs has provided insights on how this form of therapy may heal the intestine. This condition in monkeys is similar to the inflammatory bowel diseases that affects up to 1.4 million Americans.  

The study, published today in the Open-Access journal PLOS Pathogens, shows that helminths can restore the balance of gut bacterial communities to the monkeys with chronic diarrhea. Inflammatory bowel diseases are driven by a misdirected immune response against gut bacteria (the microbiome) and are often associated with alterations in gut bacterial communities (known as dysbiosis). 

"The idea for treating colitis with worms is not new, but how this therapy might work remains unclear," says the study's senior corresponding author, P'ng Loke, PhD, assistant professor of microbiology at NYU Langone Medical Center. "Our findings suggest that exposure to helminths may improve symptoms by restoring the balance to the microbial communities that are attached to the intestinal wall." 

Because inflammatory bowel diseases are more common in countries with developed economies and is rare in developing countries, researchers have hypothesized that endemic helminth infections in developing countries may offer protection against this disease. In animal models of autoimmunity these worms have suppressed inflammation, and clinical trials indicate that helminth therapy can be beneficial in inflammatory bowel diseases. 

Juvenile monkeys kept in captivity often spontaneously develop chronic diarrhea that is difficult to treat by veterinarians. Dr. Loke and his colleagues treated 5 monkeys with chronic diarrhea with microscopic helminth eggs and collected tissue samples before and after treatment. 

Tissues samples taken before treatment from sick monkeys had many more attached bacteria than healthy monkeys and the types of attached bacteria were completely altered (dysbiosis). This attachment of altered bacteria was associated with a very strong inflammatory response. After treatment, the types of bacteria attached to tissue samples were much more similar to healthy monkeys, and 4 out of 5 monkeys had less diarrhea and started to gain weight. 

Dr. Loke and colleagues are now embarking on a new clinical trial designed to study how pig helminth eggs (TSO) may relieve symptoms of ulcerative colitis (UC) and have started enrolling patients at NYU Langone Medical Center. TSO is being used because it can be produced under pathogen free conditions certified by the FDA for clinical trials and cannot be transmitted from person to person.      

Journal reference: PLoS Pathogens 


THE LINK ---> Probiotic worm treatment may improve symptoms of colitis by restoring gut bacteria to healthy state:

'via Blog this'

Wednesday, May 4, 2011

Naltrexone - general info & other conditions it could possibly treat

So many people are clueless about this treatment... Thank you FDA, we love you too.
*Naltrexone is only FDA approved for the treatment of opiate/alcohol addiction in the US*  

Low doses of naltrexone can treat Crohn's, Colitis, MS, Cancer, AIDS & an array of other autoimmune diseases (this we know because the clinical trials say so & from personal experience ....  I'm feeling better and I've only been on it for 6 days!!!! YAYYYY)

This is just basic information about naltrexone.   Click on **Other Uses** and see the list of other conditions that Naltrexone can possibly treat.. I can't believe the list.  Autism to sexual dysfunction  Whaaaaaat?

http://en.wikipedia.org/wiki/Naltrexone
http://en.wikipedia.org/wiki/Naltrexone#Other_uses

 




Sunday, April 10, 2011

LDN Study/Trial for Active Crohn's - *link*

Low Dose Naltrexone study results - show that LDN did help Crohn's Disease sufferers. 


I'm searching to find out why this drug that is said to help people with autoimmune diseases - Crohn's being just one of the diseases, is not approved by the FDA yet for the treatment of autoimmune diseases.

There are so many positives for prescribing this drug vs all the biologics that come with the risk of some very dangerous side effects. Not to mention, naltrexone is super reasonable in price, few side-effects and is effective!

I just wanted to share my findings when searching on the FDA site for clinical trials. Let me know if you find this encouraging or helpful to you.